Literature DB >> 9928476

The genetics of breast cancer susceptibility.

N Rahman1, M R Stratton.   

Abstract

Following the genomic localization and subsequent identification of the breast cancer susceptibility genes, BRCA1 and BRCA2, the basic patterns of cancer risk associated with mutations in these genes have been defined. In addition, preliminary insights into the prevalence of mutations and their contributions to cancer incidence have been acquired. Features of breast and other cancers that develop in these genetic syndromes have now been investigated and shown to differ from sporadic versions of the same neoplasms. However, several areas are complex and require further clarification. There remain discrepancies between published cancer risk estimates. Furthermore, there may be variation in cancer risk between different mutations in the same gene and there is preliminary evidence that genetic and nongenetic influences may modify risks. Finally, it is probable that the genes underlying a substantial component of susceptibility to breast cancer remain to be identified.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928476     DOI: 10.1146/annurev.genet.32.1.95

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  75 in total

1.  Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.

Authors:  B H Spain; C J Larson; L S Shihabuddin; F H Gage; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Allele age and a test for selection on rare alleles.

Authors:  M Slatkin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-11-29       Impact factor: 6.237

3.  JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

Authors:  Yan-Fen Hu; Rong Li
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

4.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

5.  BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation.

Authors:  Brian P Chadwick; Timothy F Lane
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

6.  Preface: chromosomal instability and breast cancer pathogenesis.

Authors:  Ashok R Venkitaraman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

7.  Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.

Authors:  H Ruffner; C A Joazeiro; D Hemmati; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

8.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

9.  Degradation of BRCA2 in alkyltransferase-mediated DNA repair and its clinical implications.

Authors:  Subha Philip; Srividya Swaminathan; Sergey G Kuznetsov; Sreenivas Kanugula; Kajal Biswas; Suhwan Chang; Natalia A Loktionova; Diana C Haines; Philipp Kaldis; Anthony E Pegg; Shyam K Sharan
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.